Citius Pharmaceuticals: Q1 Earnings Insights

Citius Pharmaceuticals CTXR reported its Q1 earnings results on Thursday, February 10, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Citius Pharmaceuticals reported in-line EPS of $-0.06 versus an estimate of $-0.06.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01, which was followed by a 5.88% drop in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!